APA (7th ed.) Citation

Paolisso, P., Bergamaschi, L., Santulli, G., Gallinoro, E., Cesaro, A., Gragnano, F., . . . Pizzi, C. (2022). Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: A multicenter international registry. Cardiovascular diabetology, 21(1), 77-12. https://doi.org/10.1186/s12933-022-01506-8

Chicago Style (17th ed.) Citation

Paolisso, Pasquale, et al. "Infarct Size, Inflammatory Burden, and Admission Hyperglycemia in Diabetic Patients with Acute Myocardial Infarction Treated with SGLT2-inhibitors: A Multicenter International Registry." Cardiovascular Diabetology 21, no. 1 (2022): 77-12. https://doi.org/10.1186/s12933-022-01506-8.

MLA (9th ed.) Citation

Paolisso, Pasquale, et al. "Infarct Size, Inflammatory Burden, and Admission Hyperglycemia in Diabetic Patients with Acute Myocardial Infarction Treated with SGLT2-inhibitors: A Multicenter International Registry." Cardiovascular Diabetology, vol. 21, no. 1, 2022, pp. 77-12, https://doi.org/10.1186/s12933-022-01506-8.